Role of the radiotherapy boost on local control in ductal carcinoma in situ

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Riou, Olivier ^a   Lemanski, Claire ^a   Guillaumon, Vanessa ^a   Lauche, Olivier ^a   Fenoglietto, Pascal ^a   Dubois, Jean Bernard ^a   Azria, David ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866150942     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/748196     Document Type: Review

References (37)

1. Virnig B. A., Tuttle T. M., Shamliyan T., Kane R. L., Ductal carcinoma in Situ of the breast: a systematic review of incidence, treatment, and outcomes. Journal of the National Cancer Institute 2010 102 3 170 178 2-s2.0-76349106646 10.1093/jnci/djp482
2. Mokbel K., Cutuli B., Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncology 2006 7 9 756 765 2-s2.0-33747856742 10.1016/S1470-2045(06)70861-0 (Pubitemid 44283669)
3. Barillot I., Cutuli B., Arnould L., Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard? Cancer/Radiotherapie 2004 8 1 9 20 2-s2.0-1242271184 10.1016/j.canrad.2003.09. 003 (Pubitemid 38235635)
4. Newman L. A., lanewman@umich.edu Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective. Journal of the National Cancer Institute. Monographs 2010 41 152 157 10.1093/jncimonographs/lgq018
5. Kane R. L., kanex001@umn.edu Virnig B. A., Shamliyan T., Wang S.-Y., Tuttle T. M., Wilt T. J., The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. Journal of the National Cancer Institute. Monographs 2010 41 130 133 10.1093/jncimonographs/ lgq022
6. Bijker N., n.bijker@amc.uva.nl van tienhoven G., Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective. Journal of the National Cancer Institute 2010 41 178 180 10.1093/jncimonographs/lgq025
7. Correa C., bc.overview@ctsu.ox.ac.uk McGale P., Taylor C., Wang Y., Clarke M., Davies C., Peto R., Bijker N., Solin L., Darby S., Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute 2010 41 162 177 10.1093/jncimonographs/ lgq039
8. Romestaing P., Lehingue Y., Carrie C., Coquard R., Montbarbon X., Ardiet J.-M., Mamelle N., Gérard J.-P., Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. Journal of Clinical Oncology 1997 15 3 963 968 (Pubitemid 27106278)
9. Bartelink H., h.bartelink@nki.nl Horiot J.-C., Poortmans P. M., Struikmans H., Van Den Bogaert W., Fourquet A., Jager J. J., Hoogenraad W. J., Oei S. B., Warlam-Rodenhuis C. C., Pierart M., Collette L., Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. Journal of Clinical Oncology 2007 25 22 3259 3265 10.1200/JCO.2007.11.4991 (Pubitemid 47325610)
10. Schnitt S. J., sschnitt@bidmc.harvard.edu Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics. Journal of the National Cancer Institute 2010 41 158 161 10.1093/jncimonographs/lgq031
11. Fourneret P., Artignan X., De Cornulier J., Pasquier D., Panh M. H., Payan R., Kolodié H., Vincent F., Fric D., Bernard P., Colona M., Bolla M., Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association. Cancer/Radiotherapie 2006 10 8 550 558 2-s2.0-33845287963 10.1016/j.canrad.2006.06.010 (Pubitemid 44881377)
12. Cutuli B., Cohen-Solal-le Nir C., De Lafontan B., Mignotte H., Fichet V., Fay R., Servent V., Giard S., Charra-Brunaud C., Lemanski C., Auvray H., Jacquot S., Charpentier J. C., Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. International Journal of Radiation Oncology Biology Physics 2002 53 4 868 879 2-s2.0-0037100126 10.1016/S0360-3016(02)02834-1 (Pubitemid 34722631)
13. Solin L. J., Fourquet A., Vicini F. A., Taylor M., Olivotto I. A., Haffty B., Strom E. A., Pierce L. J., Marks L. B., Bartelink H., McNeese M. D., Jhingran A., Wai E., Bijker N., Campana F., Hwang W. T., Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005 103 6 1137 1146 2-s2.0-20044376865 10.1002/cncr.20886 (Pubitemid 40328083)
14. Tunon-de-Lara C., Lemanski C., Cohen-Solal-Le-Nir C., de Lafontan B., Charra-Brunaud C., Gonzague-Casabianca L., Mignotte H., Fondrinier E., Giard S., Quetin P., Auvray H., Cutuli B., Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk. European Journal of Surgical Oncology 2010 36 12 1165 1171
15. Fisher B., Dignam J., Wolmark N., Wickerham D. L., Fisher E. R., Mamounas E., Smith R., Begovic M., Dimitrov N. V., Margolese R. G., Kardinal C. G., Kavanah M. T., Fehrenbacher L., Oishi R. H., Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet 1999 353 9169 1993 2000 2-s2.0-0033549344 10.1016/S0140-6736(99)05036-9 (Pubitemid 29271743)
16. Julien J.-P., ajpjulien@aol.com Bijker N., Fentiman I. S., Peterse J. L., Delledonne V., Rouanet P., Avril A., Sylvester R., Mignolet F., Bartelink H., Van Dongen J. A., Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 2000 355 9203 528 533 (Pubitemid 30088672)
17. Bijker N., Peterse J. L., Duchateau L., Julien J.-P., Fentiman I. S., Duval C., Di Palma S., Simony-Lafontaine J., De Mascarel I., Van de Vijver M. J., Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. Journal of Clinical Oncology 2001 19 8 2263 2271 (Pubitemid 32366979)
18. Bijker N., n.bijker@nki.nl Meijnen P., Peterse J. L., Bogaerts J., Van Hoorebeeck I., Julien J.-P., Gennaro M., Rouanet P., Avril A., Fentiman I. S., Bartelink H., Rutgers E. J.Th., Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group. Journal of Clinical Oncology 2006 24 21 3381 3387 10.1200/JCO.2006.06. 1366 (Pubitemid 46638893)
19. Dunne C., Burke J. P., Morrow M., Kell M. R., Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. Journal of Clinical Oncology 2009 27 10 1615 1620 10.1200/JCO.2008.17.5182
20. Ringberg A., Nordgren H., Thorstensson S., Idvall I., Garmo H., Granstrand B., Arnesson L. G., Sandelin K., Wallgren A., Anderson H., Emdin S., Holmberg L., lars.holmberg@akademiska.se Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast-Results from the Swedish randomised trial. European Journal of Cancer 2007 43 2 291 298 10.1016/j.ejca.2006.09.018 (Pubitemid 46123991)
21. Fisher E. R., Land S. R., Saad R. S., Fisher B., Wickerham D. L., Wang M., Costantino J. P., Wolmark N., Pathologic variables predictive of breast events in patients with ductal carcinoma in situ. American Journal of Clinical Pathology 2007 128 1 86 91 2-s2.0-34547110126 10.1309/WH9LA543NR76Y29J (Pubitemid 47121719)
22. Cutuli B., Fourquet A., Luporsi E., Arnould L., Caron Y., De Cremoux P., Dilhuydy J. M., Fondrinier E., Fourme E., Giard-Lefevre S., Le Blanc-Onfroy M., Lemanski C., Mauriac L., Sigal-Zafrani B., Tardivon A., This P., Tunon De Lara C., Kirova Y., Fabre N., Standards, options and recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004. Bulletin du Cancer 2005 92 2 155 168 2-s2.0-14544294426 (Pubitemid 40396123)
23. Fisher B., Costantino J., Redmond C., Fisher E., Margolese R., Dimitrov N., Wolmark N., Wickerham D. L., Deutsch M., Ore L., Mamounas E., Poller W., Kavanah M., Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. New England Journal of Medicine 1993 328 22 1581 1586 2-s2.0-0027241810 10.1056/NEJM199306033282201 (Pubitemid 23151917)
24. Fisher B., Land S., Mamounas E., Dignam J., Fisher E. R., Wolmark N., Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Seminars in Oncology 2001 28 4 400 418 2-s2.0-0034883290 (Pubitemid 32762083)
25. Wapnir I. L., wapnir@stanford.edu Dignam J. J., Fisher B., Mamounas E. P., Anderson S. J., Julian T. B., Land S. R., Margolese R. G., Swain S. M., Costantino J. P., Wolmark N., Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. Journal of the National Cancer Institute 2011 103 6 478 488 10.1093/jnci/djr027
26. Houghton J., j.houghton@ctg.ucl.ac.uk Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003 362 9378 95 102 10.1016/S0140-6736(03)13859-7 (Pubitemid 36831018)
27. Cuzick J., Sestak I., Pinder S. E., Ellis I. O., Forsyth S., Bundred N. J., Forbes J. F., Bishop H., Fentiman I. S., George W. D., Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. The Lancet Oncology 2011 12 1 21 29 2-s2.0-78650700810 10.1016/S1470-2045(10)70266-7
28. Emdin S., Granstrand B., Ringberg A., Sandelin K., Arnesson L. G., Nordgren H., Anderson H., Garmo H., Holmberg L., Wallgren A., SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncologica 2006 45 5 536 543 2-s2.0-33746772725 10.1080/02841860600681569 (Pubitemid 44167203)
29. Holmberg L., lars.holmberg@kcl.ac.uk Garmo H., Granstrand B., Ringberg A., Arnesson L.-G., Sandelin K., Karlsson P., Anderson H., Emdin S., Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. Journal of Clinical Oncology 2008 26 8 1247 1252 10.1200/JCO.2007.12.7969
30. Omlin A., Amichetti M., Azria D., Cole B. F., Fourneret P., Poortmans P., Naehrig D., Miller R. C., Krengli M., Gutierrez Miguelez C., Morgan D., Goldberg H., Scandolaro L., Gastelblum P., Ozsahin M., Dohr D., Christie D., Oppitz U., Abacioglu U., Gruber G., Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncology 2006 7 8 652 656 2-s2.0-33746447014 10.1016/S1470-2045(06)70765-3 (Pubitemid 44143777)
31. Wong P., Lambert C., christine.lambert@muhc.mcgill.ca Agnihotram R. V., David M., Duclos M., Freeman C. R., Ductal carcinoma in situthe influence of the radiotherapy boost on local control. International Journal of Radiation Oncology Biology Physics 2012 82 2 e153 e158 10.1016/j.ijrobp.2011.03.045
32. Ben-David M. A., Sturtz D. E., Griffith K. A., Douglas K. R., Hayman J. A., Lichter A. S., Pierce L. J., Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience. Breast Journal 2007 13 4 392 400 2-s2.0-34250822214 10.1111/j.1524-4741.2007.00447.x (Pubitemid 46985566)
33. Solin L. J., Fourquet A., Vicini F. A., Haffty B., Taylor M., McCormick B., McNeese M., Pierce L. J., Landmann C., Olivotto I. A., Borger J., Kim J. S., De la Rochefordiere A., Schultz D. J., Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. International Journal of Radiation Oncology Biology Physics 2001 50 4 991 1002 2-s2.0-0035879447 10.1016/S0360-3016(01) 01517-6 (Pubitemid 32594839)
34. Solin L. J., solin@xrt.upenn.edu Fourquet A., Vicini F. A., Taylor M., Haffty B., Strom E. A., Wai E., Pierce L. J., Marks L. B., Bartelink H., Campana F., McNeese M. D., Jhingran A., Olivotto I. A., Bijker N., Hwang W.-T., Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. European Journal of Cancer 2005 41 12 1715 1723 10.1016/j.ejca.2005.03.028 (Pubitemid 41132631)
35. Wai E. S., Lesperance M. L., Alexander C. S., Truong P. T., Culp M., Moccia P., Lindquist J. F., Olivotto I. A., Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 2011 117 1 54 62 2-s2.0-78650698502 10.1002/cncr.25344
36. Monteau A., Sigal-Zafrani B., Kirova Y. M., Fourchotte V., Bollet M. A., Vincent-Salomon A., Asselain B., Salmon R. J., Fourquet A., Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. International Journal of Radiation Oncology Biology Physics 2009 75 4 1021 1028 2-s2.0-70449721901 10.1016/j.ijrobp.2008.12.014
37. Azria D. Auvray H. Barillot I. Baumann P. Benyoucef A. Bons-Rosset F. Bontemps P. Bourgier C. Breton-Callu C. Cowen D. Cretin J. Delalande B. Denis F. Ellis S. Gaci Z. Hannoun-Lévy J.M. Hasbini A. Hennequin C. Lagrange J.L. Lartigau E. Latorzeff I. Le Blanc-Onfroy M. Lecouillard I. Lemanski C. Levy C. Maingon P. Marchal C. Monnier A. Pradier O. Racadot S. Romestaing P.Serin D. Simon J.M. Teyssier E. Tallet A. Tolédano A. Belkacémi Y., Ductal carcinoma in situ: Role of the boost, Cancer/Radiotherapie 2012 6 7 571-576